🇺🇸 FDA
Patent

US 11673860

Crystalline siponimod fumaric acid and polymorphs thereof

granted A61PA61P37/00

Quick answer

US patent 11673860 (Crystalline siponimod fumaric acid and polymorphs thereof) held by TEVA PHARMACEUTICALS INTERNATIONAL GMBH expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICALS INTERNATIONAL GMBH
Grant date
Tue Jun 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P37/00